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Total body irradiation (TBI) is part of the preconditioning regimen for allogeneic bone
marrow transplantation (alloBMT) and the procedure is associated with treatment-related
toxicity and delayed immune reconstitution. Natural killer (NK) cells develop and acquire
functional competence in close interaction with stromal bone marrow cells that are
considered relatively radioresistant compared to the hematopoietic compartment. We
thus undertook a study to assess the effect of TBI on the reconstitution of class I
MHC-specific Ly49 NK cell receptors in a rat model of alloBMT. In rats subjected to TBI
alone or followed by MHC-matched BMT, the irradiation conditioning induced a skewing
of the Ly49 repertoire. Specifically, the activating Ly49s3bright subset exhibited increased
frequency and receptor density which correlated with augmented alloreactivity relative
to untreated control rats. Our results highlight the plasticity of NK cells and indicate
that ionizing radiation (IR) affects the stromal compartment and as a consequence the
maturation and functional properties of bone marrow-derived NK cells. These changes
lasted throughout the 6 months observation period, showing that irradiation induces long
term effects on the generation of the NK cell receptor repertoire.
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Introduction
Total body irradiation (TBI) is commonly used in conditioning regimens prior to allogeneic bone
marrow transplantation (alloBMT) in the treatment of a variety of malignant and non-malignant
disorders (Wheldon and Barrett, 2001). TBI is given with the aim to eradicate malignant or
abnormal cells and provide sufficient immunosuppression to allow engraftment of transferred
hematopoietic stem cells (HSCs) (Heinzelmann et al., 2006). AlloBMT is associated with high
treatment-related toxicities and may cause severe adverse effects like infections and graft-vs.-host
disease (GvHD) (Appelbaum, 2005; Ferrara and Reddy, 2006). An HLA-matched sibling donor is
preferred to facilitate engraftment and reduce the risk of complications after transplantation (Beatty
et al., 1985).
The effect of TBI on the hematopoietic compartment is well-documented, whereas there is
limited knowledge of the effect on bone marrow stromal stem cells that survive doses of radiation
detrimental to HSCs (Chen et al., 2006; Li et al., 2007). The intravenously injected hematopoietic
stem cells home to the BM cavity early after transplantation. HSCs reside primarily in the
bone marrow within a specialized microenvironment, the HSC niche (Wang and Wagers, 2011).
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Mesenchymal stem/stromal cells (MSCs) are a main component
of the HSC niche and support hematopoiesis by releasing soluble
factors and via direct cell-cell interactions with hematopoietic
stem- and progenitor cells (Mercier et al., 2012). Lymphocytes
develop from BM-derived HSCs through a common lymphoid
progenitor (CLP) (Luetke-Eversloh et al., 2013). While T-
cells are generated in the bone marrow and educated in the
thymus, Natural killer (NK) cell education and differentiation,
including acquisition of both activating and inhibitory receptors,
occur primarily in the bone marrow. The process of receptor
acquisition and NK cell education remains poorly understood.
The MHC-I-specific NK cell receptors and ligands [killer cell
immunoglobulin-like receptors (KIRs) and HLA in humans
and the analogous Ly49 receptors and RT1 in rats] are
highly polymorphic and inherited independently as a haplotype
(Rolstad et al., 2001; Yokoyama and Plougastel, 2003). Functional
competence of NK cells requires engagement of a self MHC-
I-specific inhibitory receptor, a process termed education or
licensing, a mechanism that also acquires tolerance to self (Orr
and Lanier, 2010).
NK cells in the periphery expressing inhibitory receptors
that can bind “self ” MHC-I are considered licensed with
cytokine-producing and cytotoxic functions. The “missing-self ”
hypothesis proposed a principle for NK cell recognition, where
the altered or absent expression of MHC-I molecules is sufficient
to induce activation. NK cell responses are subjected to the
balance of signaling through inhibitory vs. activating receptors
(Rolstad et al., 2001; Moretta et al., 2002). In earlier experiments,
we observed that rats exposed to whole body gamma irradiation
prematurely gray, whether bone marrow transplanted or not.
A study in mice suggests that ionizing radiation induces DNA
damage and triggers differentiation of MSCs into melanocytes.
The premature graying of hair is a physiological consequence
of reduction in the pool of remaining MSCs (Inomata et al.,
2009). To examine the effect of IR on the MSCs in the BM
microenvironment, we monitored the recovery of peripheral NK
cell subsets that had been differentiated and educated in an
irradiated host and thereby investigated a possible influence of
IR on the NK cell development.
We have employed a rat non-myeloablative transplantation
protocol involving sublethal TBI and bone marrow as the source
of HSCs. The PVG rat expresses an extensive repertoire of both
inhibitory and activating Ly49 receptors and was used as model.
Here we compare the expression of Ly49 NK cell subsets in a
group of rats subjected to TBI followed by MHC-matched BMT
with those of untreated negative control animals. To examine
the influence of TBI on the mesenchymal vs. the hematopoietic
compartment, a group of rats was exposed to irradiation alone,
without transfer of HSCs. After 6 months of follow-up, donor-
derived NK cells from the different groups were evaluated for
cytolytic activity against MHC-disparate target cells in functional
NK cell cytotoxicity assays in vitro and in vivo.
Materials and Methods
Animals and Experimental Approval
The panel of MHC-congenic rat strains PVG.7B (RT1c), PVG.1N
(RT1n) and PVG.1U (RT1u) on the Piebald Virol Glaxo (PVG)
background bred at the Institute of Basic Medical Sciences,
University of Oslo, were originally a kind gift from Dr. Geoffrey
Butcher, the Babraham Institute, Cambridge. PVG (RT1c) rats
were purchased from Harlan Laboratories. PVG.7B rats (RT1c,
CD45.2,) are identical to PVG (RT1c, CD45.1) except for the
allelic variant of the leukocyte common antigen CD45 that can
be detected with the anti-CD45.2mAb (His41) (Kampinga et al.,
1990). PVG.7B rats were used as donors in the transplantation
experiments to enable flow cytometric tracking of donor
(His41+) NK cells, while PVG rats served as recipients. Male
rats, 8–12 weeks old and weighing 200–250 g, were randomly
divided into experimental groups. The animal studies were
approved by the Experimental Animal Board under the Ministry
of Agriculture of Norway and conducted under license number
12.1515 in conformity with “the Norwegian Regulations on
Animal Experimentation” and “The European Convention for
the Protection of Vertebrate Animals used for Experimental and
other Scientific Purposes.” The laboratory animal facilities are
subject to a routine health monitoring program and the animals
were approved free of infectious organisms according to FELASA
recommendations.
Total Body Irradiation and Bone Marrow
Transplantation
Rats subjected to γ-irradiation alone were exposed to a dose
of 6 Gy using a 137Cs source (Gammacell 3000 Elan, MDS
Nordion), which allowed repopulating of hematopoietic cells
in the irradiated rats. Recipient rats for BMT were irradiated
with 8.5 Gy, which is close to the median lethal dose (LD50)
in the PVG rat, estimated in an earlier study (Nestvold et al.,
2008). Isolation of bone marrow cells (BMCs) was obtained by
flushing the tibias and femurs with 20ml Gibco RPMI 1640
containing 2% FBS (Invitrogen). Cells were passed through a
nylon cell-strainer and mononuclear cells purified by density
gradient centrifugation on Nycoprep 1.077A (Medinor ASA).
BMCs were depleted of T-cells with a combination of the mouse
monoclonal antibodies, culture supernatant and ascites fluid,
against CD5 (OX19), TCRα/β (R73) and anti-mouse IgG-coated
Dynabeads (Invitrogen). Recipient rats were anaesthetized with
Hypnorm (fentanyl citrate and fluanisone, VetaPharma Ltd.) at
doses of 0.6ml/kg that provided sufficient degree of sedation
and analgesia through the entire transplantation procedure. After
TBI, the recipient rats were injected intravenously 1–2 h later
with 25 × 106 BMCs. The animals were evaluated daily for
clinical signs of transplant-related adverse events throughout the
follow-up period of 6 months.
Flow Cytometry and mAbs
Blood samples, 0.3ml of blood from the lateral tail vein,
were collected in 75mm heparinized tubes (Drummond,
Hemato-Clad, Sigma-Aldrich) and lysed via incubation in
0.8% ammonium chloride lysis buffer. Mononuclear cells
were stained with monoclonal antibodies against CD3 (G4.18-
FITC/PE), NKR-P1A/CD161a (10/78-FITC/PE) purchased
from BD Biosciences, CD45.2 (His41-FITC) kindly provided
by Dr. Kampinga, University of Groningen, the Netherlands.
Anti-NKR-P1B (STOK27-Alexa647) was produced from
hybridomas and conjugated according to standard protocols.
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The biotinylated antibodies against Ly49i2 (STOK2), Ly49s3
(STOK6), Ly49s3,i3,s4,i4 (DAR13), Ly49s5,i5 (Fly5), Ly49
cocktail (STOK2, STOK6, DAR13, Fly5), NKR-P1A (3.2.3) and
CD3 (G4.18) were followed by RPE-Cy5-conjugated streptavidin
(Dako). During long-term studies, blood samples were pooled
from untreated rats at different ages and used as controls. For
each analysis, the level of fluorescence intensity was adjusted
to samples from the control rats. All flow cytometry data
was analyzed on a FACScalibur cytometer equipped with the
CellQuest software (BD Biosciences).
In Vitro NK Cytotoxicity Assays
NK cells from spleens of treated and untreated rats were
assessed for cytolytic activity in a 51Cr-release assay performed
in accordance with previously described procedures (Naper et al.,
1995). Splenic mononuclear cells were obtained by Lymphoprep
(Axis-Shield) density gradient centrifugation.
NK cells for IL-2 activation were isolated from splenocytes by
negative selection with Dynabeads (M-450 SaM IgG, Invitrogen)
coated with anti-CD3mAb followed by positive selection with
anti-NKR-P1A mAb-coated beads. Purified NK cells were
cultured in medium (RPMI 1640, 25mM Hepes, L-glutamine,
100 U/ml penicillin, 100µg/ml streptomycin, 5 × 10−5M 2-
ME, 1mM sodium pyruvate and 0.1mM non-essential amino
acids and 10% FBS, all from Invitrogen), supplemented with
rat recombinant IL-2. In antibody-blocking experiments, 5µg
of purified mAb DAR13 was added to the effector cells 20min
before addition of targets.
Freshly isolated NK cells were purified from splenocytes using
theMACS cell separation system (Miltenyi Biotec) to first deplete
the mononuclear cell population of CD3+ cells and then enrich
for NKR-P1A+ cells. T-cells were depleted by incubation with
biotinylated antibodies against CD5 (OX19) and CD6 (OX52)
followed by anti-biotin microbeads and negative MACS selection
using an LS column. NK cells were positively selected by anti-
NKR-P1A mAb (3.2.3-biotin) in combination with anti-biotin
microbeads.
Target cells were ConA-activated lymphoblasts from PVG.1N
or the NK-sensitive mouse lymphoma cell line, YAC-1. Target
cells (10 × 106 cells ml−1) were incubated with 3.7 MBq of
Na512 CrO4 ml
−1 (Amersham) at 37◦C for 1hr. 51Cr-labeled
targets (1 × 105 cells ml−1per well) and serial dilutions of
effector cells at the indicated E:T ratios, were plated in 100µl of
complete RPMI 1640 in U-bottomed 96-well plates. 51Cr-release
was measured after incubation for 4 h at 37◦C. Supernatants
were harvested with a Titertek harvesting system (Skatron) and
radioactivity assessed in a gamma counter (Beckmann). Lysis was
determined using the formula (experimental cpm – spontaneous
cpm) × 100/(maximum cpm - spontaneous cpm). Spontaneous
cpm was measured by incubating targets in medium alone and
was <15% of total cpm.
In Vivo Measurement of Allogeneic Lymphocyte
Cytotoxicity (ALC)
Determination of ALC was performed as previously detailed
(Rolstad et al., 1985; Løvik et al., 2001). In short, mesenteric
and cervical lymph node cells from donor rats were filtered
through a nylon cell-strainer and 10–15 × 106 lymphocytes
per ml were labeled with 0.4 MBq Na512 CrO4ml
−1
.
51Cr-labeled
cells (10–15 × 106 per rat) were injected intravenously and
after 24 h recipient rats were terminated and cervical and
mesenteric lymph nodes harvested. Radioactivity was assessed
using a gamma counter (Beckman), where ALC is defined as the
ratio of radioactivity retained permg lymph node of allogeneic
versus syngeneic recipients, i.e., the lymph node (LN) index.
Levels of radioactivity are a measurement of the degree of
donor lymphocyte eradication, where a lymph node index < 0.5
indicates a strong ALC and a rapid elimination by recipient NK
cells.
Statistical Analysis
Statistical significance between test and control groups was
evaluated using a non-parametric Wilcoxon two sided rank test
or aWilcoxon-van Elteren test formultiple paired sets of samples.
P-values at ≤ 0.05 were considered significant.
Results
Rapid Recovery of NK Cells after T-cell Depleted
Bone Marrow Graft Enriched for NK Cells
The composition of T- and NK cells in the T-cell depleted (TCD)
BM graft used to reconstitute the animals is shown (Figure 1A).
The reduction of T-cells after depletion was sufficient to avoid
any adverse events. The kinetics of NK cell reconstitution was
similar between the irradiated and BMT groups. In line with
clinical HSCT (Seggewiss and Einsele, 2010), NK cells were
the first lymphocytes to recover and appeared in quantities
similar to those found in healthy donors already 5 weeks after
transplantation (Figure 1B). The total NK population reflected
donor-derived NK cells verified by the use of donor PVG.7B
with CD45.2 background in combination with recipient PVG
expressing CD45.1.
Irradiated Rats Prematurely Gray
A group of irradiated, BM-transplanted and untreated PVG rats
were kept for 12 months for monitoring of possible chronic or
late effects associated with radiation therapy or BMT. The only
macroscopic changes observed were the grayness in fur color
accompanied by relative hair loss in treated rats compared to
untreated age-matched rats (Figure 2).
NK Cell Education after BMT: Influence of
Irradiation on the Development of Donor-derived
NK Cells
The prematurely graying of the coats in rats receiving TBI may be
a sign of genetoxic stress induced by ionizing radiation (Inomata
et al., 2009). This observation led us to investigate the impact and
effect of radiation exposure on the development of the NK cell
repertoire over an extending period of time after transplantation.
Several Ly49 receptors have been characterized in the rat (Naper
et al., 2002, 2005, 2010; Kveberg et al., 2006a,b) (Table 1).
Subsets of NK cells in peripheral blood were quantified by flow
cytometry in terms of frequency of receptor positive cells and
by estimation of mean fluorescence intensity (MFI) (Figure 3).
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FIGURE 1 | Rapid recovery of NK cells after MHC-matched BMT. (A)
Representative dot plots showing the frequencies of T cells
(CD3+/NKR-P1A/B−, upper left panel), NKT cells (CD3+/NKR-P1A/B+,
upper right panel) and NK cells (CD3−/NKR-P1A/B+, lower left panel) among
the mononuclear bone marrow cells used to reconstitute the rats before (right
plot) and after (left plot) depletion of T-cells. (B) A standard volume of
peripheral venous blood was collected from irradiated PVG, MHC-matched
(PVG.7B→PVG) BM-transplanted rats and PVG controls at indicated weeks
after treatment and processed for flow cytometry. The kinetics of total NK cell
(CD3−NKR-P1A+ lymphocytes) counts is shown. Values are expressed as
average ± SD and data are representative of two independent experiments
with six rats per group.
FIGURE 2 | Irradiated rats prematurely gray. Depicted is the change in fur
color in a rat 1 year after TBI conditioning followed by MHC-matched BMT
(photo left side). The right side photo shows an age-matched untreated rat, in
which the fur color is unchanged and normal.
The Ly49mAbs STOK2 and STOK6 interact with an inhibitory
and an activating receptor respectively. In MHC-matched BM-
transplanted rats the density level of Ly49i2 was similar to
untreated rats, while Ly49s3 expression was persistently higher.
The mAbs DAR13 and Fly5 cross-react with both activating
and inhibitory receptors and although the subsets defined by
these antibodies were all increased in proportions their relative
contribution is not known or possible to evaluate by flow
TABLE 1 | Monoclonal antibodies against NK cell receptors with strain
distribution of their corresponding ligands.
mAb Receptor Ligand Produced in
STOK2 Ly49i2 RT1-A1c DA rats
Present in PVG
STOK6 Ly49s3 RT1-CE DA rats
High expression in PVG.1N
Low expression in PVG
Absent in PVG.1U
DAR13 Ly49s3,i3,s4,i4 RT1-CE Balb/c mice
High expression in PVG.1N
Low expression in PVG
Absent in PVG.1U
Fly5 Ly49s5,i5 RT1-CE Balb/c mice
Absent in PVG
STOK27 NKR-P1B Clr11 BN rats
Present in all haplotypes
RT1-1A : classical MHC-I.
RT1-CE : non-classical MHC-I.
PVG.1N : MHC complex derived from BN.
PVG.1U : MHC complex derived from AO.
cytometric analysis. The NKR-P1B receptor, the ligand of which
is encoded outside the MHC, exhibited a higher expression
level in BM-transplanted and irradiated rats compared to
controls. Rats subjected to irradiation alone, showed an increased
expression of all the MHC-I-dependent Ly49 receptors. In this
scenario, the hematopoietic compartment is exposed to IR and
also account for the alteration in the receptor repertoire. In
all the treated animals we found an overall expansion of the
Ly49 subsets, while the NKR-P1B subset decreased relative to
untreated rats, summarized in Figure 4.
Upregulation in the Activating Ly-49s3bright
Subset in MHC-matched Transplanted Rats
The expression level of Ly49s3 was enhanced in treated rats,
determined by labeling with the STOK6mAb, which is specific
but has low affinity for Ly49s3. To assure the identity of
the Ly49s3 receptor, we combined the STOK6mAb with the
DAR13mAb, which expresses high affinity for Ly49s3 as well
as Ly49i3,s4,i4. Labeling with these two mAbs using different
fluorochromes, revealed a distinct Ly49s3bright population
(Figure 5). It was evident that the Ly49s3 receptor showed
increased receptor expression in rats with no (PVG.1U) or low-
affinity (untreated PVG) ligand and decreased expression in
PVG.1N, which exhibits a high-affinity ligand. Results from the
control rats demonstrated that NK cells in peripheral blood
follow the principle of ligand-dependent receptor expression as
shown in earlier murine studies that NK cells developing in the
presence of their cognate ligands, express lower levels of the
corresponding Ly49 receptors and vice versa. There was a notable
increase in the size of the Ly49s3 subset in the MHC-matched
transplanted group compared to untreated PVG rats and the
increased amount of this subset in the irradiated PVG group,
above the level of PVG.1U controls, lacking the cognate ligand.
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FIGURE 3 | Total body irradiation induced alterations in the NK cell
receptor repertoire. Peripheral blood samples acquired at denoted weeks
from irradiated, BM-transplanted (PVG.7B→ PVG) and untreated rats on
gated NK cells stained for the indicated receptors. Line diagram upper panel
depicting the MFI (average ± SD) of the different Ly49 subsets and the
NKR-P1B subset using six rats in each group per time point. Bar diagrams
lower panel charting the frequency of the different NK cell subsets for each
group of treated and untreated rats. The four parallel columns represent
values from the same weeks after treatment as the diagrams with the MFI
data, i.e., week 3, 5, 8, and 26 from left to right. Values are expressed as
average ± SD. Data are representative of two independent experiments with
six rats per group per time point.
Increased Frequency of Ly49 Subsets in
Donor-derived NK Cells was Associated with
Higher Degree of In Vitro and In Vivo Cytotoxicity
In earlier studies using MHC-congenic rat strains, the DAR13+
subset in PVG rats is assumed to be mainly responsible
for the cytotoxic potential against MHC-mismatched targets
(Kveberg et al., 2006b). To evaluate the cytolytic capacity of
the DAR13+population, we tested Il-2 activated NK cells from
PVG against MHC-mismatched PVG.1N lymphoblasts that were
efficiently killed (Figure 6A). Most of the reactivity in the
first combination was among the DAR13+ (Ly49s3,i3,s4,i4)
NK cells, since enrichment of this subset increased the
cytotoxic response. The effect of DAR13 blockade of the
total NK effector cell population was not complete. This
may be due to incomplete receptor inhibition or indicating a
significant contribution of other forms of stimulatory NK cell
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FIGURE 4 | Irradiation was associated with a skewing toward the
Ly49+subsets. Proportion of the alloreactive Ly49+ population (upper left
quadrant) vs. the non-alloreactive NKR-P1B+ population (lower right quadrant)
from irradiated, BM-transplanted (PVG.7B→ PVG) and untreated controls.
Numbers in quadrants show the percentage of cells in each quadrant. Data
are representative of three independent experiments.
recognition, e.g., upregulation of NKG2D ligands on ConA
blasts.
To investigate whether the increased proportion of Ly49
receptors and the enhanced levels of the Ly49s3bright receptor
in the irradiated rats or the irradiated bone marrow chimeras
vs. untreated rats were accompanied by a change in the
cytotoxic potential, we performed in vitro cytotoxicity assays
against the same MHC-mismatched target (PVG.1N). Since
IL-2 activated NK cells may show broader cytolytic response
not necessarily connected only with allospecificity, we here
tested alloreactivity of freshly isolated NK cells (Figure 6B).
NK cells from MHC-matched transplanted and irradiated
PVG rats killed PVG.1N ConA blasts avidly and slightly
more effective than untreated PVG controls (P < 0.05).
PVG.1N NK cells as controls were non-lytic against syngeneic
blasts. NK cells from both treated and untreated rats killed
the standard NK tumor target YAC-1 to the same degree
(Figure 6C).
Upregulation of the activating Ly49s3bright subset of donor-
derived NK cells after MHC-matched BMT may provide an
explanation for the increased cytolytic capacity of these NK
cells toward PVG.1N blasts in vitro. We therefore extended
cytotoxicity assessment in vitro to an in vivo assay for NK
alloreactivity termed Allogeneic Lymphocyte Cytotoxicity (ALC)
(Rolstad et al., 1985). Here we also employed additional target
cells with a different MHC haplotype (PVG.1U). Table 2 shows
elimination of transplanted 51Cr-labeled PVG.1N or PVG.1U
lymphocytes 24 h after iv. transfer in treated and untreated
groups of recipients. The ALC lymph node (LN) index in MHC-
matched transplanted rats and PVG rats exposed to irradiation
alone was lower than for untreated PVG rats demonstrating
stronger rejection of MHC disparate targets in treated rats.
The difference was significant (P < 0.05) in rats injected
with PVG.1N lymphocytes, and there was also a tendency to
increased elimination after injection of PVG.1U cells although
the small numbers did not allow statistical analysis. Thus, the
rapid eradication of lymphocytes in vivo correlated closely with
our in vitro findings and indicates that irradiation alone had an
enhancing effect on the ability of NK cells to eliminate allogeneic
lymphocytes.
FIGURE 5 | Upregulation of the activating Ly49s3bright subset in
irradiated rats. Representative dot plots from blood samples of the treated
groups (left panel), where numbers denoted in plots represent the percentages
of NK-gated Ly49s3bright expressing cells (upper right quadrant), compared to
untreated control rats (right panel) possessing no ligand expression (PVG.1U)
low ligand levels (PVG) or high ligand expression (PVG.1N) for Ly49s3. Data
are representative of three independent experiments.
TABLE 2 | In vivo allogeneic cytotoxicity (ALC).
Recipient Donor PVG.1N Donor PVG.1U
n LN index n LN index
Irradiated PVG 6 0.12 ± 0.03 2 0.05 (0.04–0.05)
BMT (PVG.7B→ PVG) 6 0.13 ± 0.03 2 0.05 (0.05)
untreated PVG 6 0.25 ± 0.04 2 0.12 (0.11–0.12)
PVG.1N : MHC complex derived from BN.
PVG.1U : MHC complex derived from AO.
In vivo cytolytic activity of donor-derived NK cells at week 26 in treated groups compared
to untreated controls (PVG). A lymph node (LN) index < 0.5 indicates rejection of the
inoculated radiolabeled MHC-disparate lymphocytes. Numbers are average ± SD for
donor PVG.1N recipients with six rats per group. Ranges of values are given for donor
PVG.1U recipients with two rats per group. Data are pooled from two independent
experiments.
Discussion
One salient feature of both the Ly49 expression and the NK
alloreactivity data was that irradiated PVG rats and MHC-
matched transplanted rats displayed a higher proportion of
Ly49+ NK cells and an upregulation of the Ly49s3bright subset,
which in turn led to augmented NK alloreactivity in vivo
compared to untreated PVG rats. Long term studies showed
altered expression frequencies and levels of these receptors that
Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 May 2015 | Volume 3 | Article 34
Nestvold and Rolstad Irradiation affects NK receptor expression
FIGURE 6 | Expression levels of NK cell Ly49 receptors correlated
with the cytolytic capacity. 51Cr -release assays showing the alloreactive
potential of IL-2-activated PVG NK cells towards PVG.1N ConA-blasts (A).
“PVG DAR13+” is subpopulations enriched for Ly49s3,i3,s4,i4 receptors and
“PVG DAR13-block” refers to blocking experiment by adding DAR13mAb to
the cytotoxicity assay of the complete NK cell population. Ex vivo isolated
splenic NK cells from treated rats at week 26 and untreated controls tested
at varying effector: target (E:T) ratios against (B) PVG.1N ConA blasts and (C)
YAC-1 cells. The results are reported as average of cpm ±SD of triplicates
from two independent experiments.
were stable for several months and not a transient phenomenon
connected to recovery of the NK cell population early after
irradiation and BMT. These persistent alterations suggest that
IR may lead to permanently changes in receptor expression of
donor-derived NK cells. The results indicate that development of
the NK cell repertoire after TBI does not precisely mimic normal
ontogeny of NK cells.
The bone marrow is considered the main site of NK cell
development, although extramedullary sites also can support NK
cell differentiation (Luetke-Eversloh et al., 2013; Yu et al., 2013).
MSCs do not engraft after BMT and stroma remains to be of host
origin (Dickhut et al., 2005; Rieger et al., 2005). Radiosensitive
HSCs undergo apoptosis in response to low doses of IR exposure
whereas MSCs are characterized as more radioresistant (Sugrue
et al., 2013). Ionizing radiation may directly produce DNA
double strand breaks (DSBs) and is also related to an increase
in cellular stress and formation of reactive oxygen species (ROS)
(Hoeijmakers, 2009). ROS induce oxidative cellular damage and
are involved in mediation of acute and chronic inflammatory
responses. MSCs reside in BM niches and the hypoxic conditions
provide a radioprotective environment. MSCs are shown to
possess a robust antioxidant system for ROS detoxification
and an effective DNA damage response (DDR) contribute to
the radioresistance of MSCs (Sokolov and Neumann, 2013).
Preconditioning with TBI may not only rapidly alter soluble
and insoluble components of the microenvironment, but also
induce chronic effects by inflammation and oxidative stress. We
hypothesize that niche composition may change under these
conditions and convert “self ” environment to “altered self,”
explaining the changes in Ly49 receptor expression after TBI.
The relevance of non-targeted biological responses of ionizing
radiation therapy (RT) was first discovered and described
by Mole (1953). Multiple case studies have documented
radiation-induced effects that are designated as bystander effects
(in adjacent unirradiated cells), abscopal effects (in unirradiated
tissues distant to the irradiated area), and cohort effects (between
irradiated cells within the irradiated field) (Blyth and Sykes,
2011). The responses involve intercellular communication and
soluble factors released into the local environment and the
biological changes may have both harmful and potentially
beneficial consequences. However, the precise mechanisms and
pathways responsible for these phenomena have not yet been
fully elucidated.
NK cell tolerance is established in the bone marrow,
whereas T-cells undergo maturation and tolerance induction
in the thymus. The effect of radiation exposure on thymus-
dependent T-cell reconstitution is incompletely understood.
Thymus dysfunction after irradiation preconditioning is related
to functional impairment of the thymic stromal cells. The
modifications in the stromal compartment may influence
maturation, TCR repertoire selection and education to self-
tolerant T-cells (Chung et al., 2001; Kelly et al., 2008). Although
poorly investigated, ionizing radiation may as well affect the
induction of tolerance in developing NK cells by altering the
marrow stromal microenvironment.
The effect of TBI on the NK cell development was associated
with expansion of the Ly49 repertoire. All Ly49 receptors
identified with our antibodies increased in frequency, whether
they were exposed to their cognate MHC-I ligand in PVG
(Ly49i2 and Ly49s3,i3,s4,i4) or the ligand was absent (Ly49s5,i5).
Assumedly, this expansion could be ligand-dependent, e.g.,
MHC-I or stress-induced ligands altered by TBI or ligand-
independent, e.g., cytokine driven response to irradiation. Most
notably, in the BM-transplanted rats the density level of the
activating Ly49s3bright receptor was significantly increased after
TBI whereas the receptor expression of the inhibitory Ly49i2
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was unchanged compared to untreated control rats. The process
of receptor expression during development of NK cells requires
trans interactions with MHC-I on hematopoietic cells and
stromal cells. In the PVG rat, the Ly49i2 receptor is the main
inhibitory receptor and the alloreactivity appears confined to the
activating Ly49s3 subset (Naper et al., 1998, 2002). The difference
in receptor expression levels of the Ly49s3 receptor between
donor-derived NK cells in transplanted rats and NK cells in non-
irradiated controls, indicates that IR creates conditions in the
BMmicroenvironment leading to upregulation of activating Ly49
receptors in favor of responsiveness. Along these lines our data
suggest a relation to the stromal compartment and presumably
by altered expression of activating ligands as a consequence of
irradiation.
We aimed to correlate the preconditioning irradiation with
a change in the Ly49 repertoire post-transplant along with
augmented Ly49-mediated cytotoxicity. While the recovery of
adaptive immunity is delayed, NK cells rapidly recover after
BMT and may be important in the early phase of immune
reconstitution. It is intriguing to speculate, that irradiation
conditioning may serve as a useful adjuvant to maximally alert
viral resistance and anti-tumor effects of NK cells expressing
activating Ly49 receptors (Ruggeri et al., 2002). Susceptibility to
cytomegalovirus (CMV) reactivation after HSCT is associated
with immunodeficiency in the host early post-transplant,
induced by the conditioning regimen. Several MHC-I-dependent
activating NK cell receptors have been shown to recognize CMV
and may play an important role in the first line defense against
infections following HSCT (Orr et al., 2010; Marras et al., 2011).
The prerequisite for therapeutic utilization of NK cells is a
better understanding of the NK cell developmental pathways
following preconditioning regimens and hematopoietic stem cell
transplantation. The knowledge can further be used for improve
the efficacy of HSCT and to design specific NK cell-based
immune therapies.
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